Reflecting financial, legal, and scientific expertise, the Beech Tree Board of Directors includes:
Mr. Ackerman has been involved with entrepreneurial endeavors and sales for most of his professional life. From 1967-1980, he had a successful career with Home Life of New York where he was a member of the Hall of Fame and a Charter member of the Top of the Round Table. Since 1980 he has been an investment banker for research and technology companies, raising over $50,000,000 for early-stage companies. He is also an angel investor in technology and renewable energy companies, and in a LEEDS community in the Mohave Desert which will incorporate hydroponic farming, water production, solar power generation, and residential and resort facilities. He also serves as a Director of The Mohave National Preserve Conservancy as well as a Director of Cooper Riis, a healing community.
As Chief Merchandising Officer since 1998, Mr. Belk has been instrumental in the notable success of Belk, Inc., the largest, privately owned, retail department chain in the United States. A member of the Board of Directors for Belk, Inc., and Coca Cola Bottling Company Consolidated, Mr. Belk also serves on numerous educational and civic boards. He holds an MBA from the University of North Carolina at Chapel Hill.
Now retired, Jeff Eckmann served as Group President for Reynolds American, Inc., where he had responsibility for four of RAI’s five business units. His responsibilities for RAI also included corporate strategy and development and mergers and acquisitions. Previously, he was Senior Vice President and Chief Financial Officer for Brown & Williamson Tobacco Corporation, having led the integration of the 2004, $4.5 billion merger between R.J. Reynolds and Brown & Williamson. Mr. Eckmann began his professional career with Price Waterhouse. He currently serves on the board of Alliance One International and chairs its audit committee. He also serves on the board and executive committee of the Northern Illinois University Foundation. He is a graduate of Northern Illinois University and the Harvard Business School Advanced Management Program.
Mr. Glasson is in private practice in Providence, Rhode Island. A graduate of Georgetown University and Suffolk University Law School, he concentrates his practice in the areas of real estate development and corporate law. Mr. Glasson previously represented Milkhaus Laboratory, Inc., as local counsel.
After graduating from Tufts University Medical School, Dr. Kramer completed a pediatric residency at the Yale University School of Medicine and later the Executive MBA Odyssey Program at the Harvard Business School. His distinguished career includes serving as Chief Pediatric Resident and Pulmonary Fellow at the University of Texas Southwestern Medical Center. He is currently the medical advisor for numerous corporations and civic organizations such as the Dallas Museum of Art and Dallas Children's Museum. He is also a Director on several medical and community Boards.
Beech Tree’s President & CEO, Dr. McMichael developed the world’s first live-virus fish vaccines for use in hatchery populations, and is an Alzheimer’s disease pioneer, having licensed 30+ patents to Elan Corp. plc, to support their Alzheimer’s initiative. He now holds more than 100 patents with twice that pending worldwide. His experience also includes Professor of Biology and Health Sciences at Edinboro University in Pennsylvania, General Manager for ImmunoTherapeutics, Vice President of Molecular Rx, Inc., Founder and President of Milkhaus Laboratory, Inc., and Founder and President of The Institute for Therapeutic Discovery, a not-for-profit organization focused on bridging biochemistry and biophysics in order to better illuminate homeodynamics, a state of physiological equilibrium associated with health and healing.
Comprising a 42-year career, Mr. Ross held senior management and executive level positions in sales, marketing, and market access strategies with medical technology companies such as Baxter, Biomet, Medtronic and Kinetic Concepts. Specifically with regard to market access strategies, Mr. Ross served as Vice President, Health Care Economics and Reimbursement for divisions of Medtronic and Kinetic Concepts whose products focused on advanced spinal, cardiovascular and wound care interventional technologies. From 1992-96, Mr. Ross was President & CEO of Osteodyne, a start-up company with a proprietary and novel treatment for osteoporosis. Presently, as President & CEO of Laird & Associates, Inc., Mr. Ross provides advisory services to early stage medical products companies.
Mr. Ryan is retired as Chairman of the Board of TD Bank, N.A. Prior to joining the bank in 1989, he served as President of the Bank of New England North in Lowell, Massachusetts, and as Executive Vice President of Community Banking for the Bank of New England in Boston. Earlier in his career, he was President of BNE Baystate, a commercial bank subsidiary of the Bank of New England, and a Vice President of the Bank of New England. In addition, Mr. Ryan has served as a Board Member of TD Bank Financial Group, Group Head, U.S. Personal and Commercial Banking, Vice Chair of TD Bank Financial Group, and President and Chief Executive Officer of TD Banknorth Inc. During this period, Mr. Ryan oversaw the growth of the bank from a small 2 Billion dollar regional bank to a large 45 Billion dollar U.S. franchise, as a result of 29 bank acquisitions. In 2005, the bank was recognized by Forbes magazine as the best managed bank in America. He is a Director of WellPoint, Inc., Chairman of the Board of Unum, serves as a Trustee of the Libra Foundation, and is Chairman of the U.S. Biathlon Foundation. He is also on the Board of Advisors at the University of New England and Emeriti Trustee of Colby College.